Latest Breaking News On - Doublet therapy - Page 1 : comparemela.com

Men with metastatic prostate cancer live longer thanks to new drugs, study finds

Men with metastatic prostate cancer live longer thanks to new drugs, study finds
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Uppsala lanMarcus westerbergChristian corsiniUppsala universityNational prostate cancer registerDepartment of surgical sciences at uppsala universitySurgical sciencesSan raffaele hospitalSurvival trendDoublet therapy

Dr Wise on Key Trials Establishing Treatment Intensification as a SOC in mHSPC

David R. Wise, MD, PhD, discusses key trials establishing the benefit of hormone therapy– or chemotherapy-based doublet therapy for patients with metastatic hormone-sensitive prostate cancer

Langone healthDepartment of medicineDepartment of urologyGrossman school of medicineLangone health perlmutter cancer centerGenitourinary medical oncologyPerlmutter cancer centerOnclive tvMetastatic hormone sensitive prostate cancerAndrogen receptor signaling inhibitorsTreatment intensificationTriplet therapyDoublet therapy

Selecting Optimal Therapy for Advanced Non-Clear Cell RCC

Focusing their discussion on a real-world patient scenario, expert panelists discuss treatment options in the setting of advanced non-clear cell renal cell carcinoma.

Evolving treatmentsAdvanced renal cell carcinomaOptimal therapyAdvanced non clear cellRenal cell carcinomaRcc cancerKidney cancerAdvanced rccMetastatic rccAsco 2023Asco annual meetingNon clear cellNon clear cell rccNon clear cell kidney cancerCombination therapyNovel therapy

Dr Wise on the Optimal Use of Treatment Intensification in mHSPC

David R. Wise, MD, PhD, discusses changes in the optimal use of intensified treatment regimens in patients with metastatic hormone-sensitive prostate cancer.

Langone healthGrossman school of medicineDepartment of urologyDepartment of medicineLangone health perlmutter cancer centerGenitourinary medical oncologyPerlmutter cancer centerOnclive tvMetastatic hormone sensitive prostate cancerAndrogen receptor signaling inhibitorsTreatment intensificationTriplet therapyDoublet therapy

Metastatic CRPC: Advent of PARP Inhibitors

Comprehensive insight on the evolving role of PARP inhibitors in metastatic castration-resistant prostate cancer and clinical trials in this setting.

Key updatesMetastatic prostate cancer treatmentProstate cancerMetastatic castration resistant prostate cancerCastration resistant prostate cancerParp inhibitionParp inhibitorsNovel therapyCombination therapyDoublet therapyPropel trialPropel studyMagnitude trialMagnitude studyTalapro 2